serum pepsinogen (PG) tests correlate with the occurrence of gastric atrophy and intestinal metaplasia. However, because of its low sensitivity, Huang et al report that in North America, where Helicobacter pylori prevalence is low (8%) and the use of proton pump inhibitors is frequent, the discrimination value for gastric preneoplastic lesions, atrophic gastritis, and intestinal metaplasia of gastropanel biomarkers is too low to obtain good results.

Biomarkers and OLGIM Stage for Prospective Preneoplastic Risk Stratification

Cannizzaro R.
Conceptualization
2021-01-01

Abstract

serum pepsinogen (PG) tests correlate with the occurrence of gastric atrophy and intestinal metaplasia. However, because of its low sensitivity, Huang et al report that in North America, where Helicobacter pylori prevalence is low (8%) and the use of proton pump inhibitors is frequent, the discrimination value for gastric preneoplastic lesions, atrophic gastritis, and intestinal metaplasia of gastropanel biomarkers is too low to obtain good results.
2021
Pubblicato
https://www.sciencedirect.com/science/article/abs/pii/S1542356521001464?via=ihub
File in questo prodotto:
File Dimensione Formato  
bioamrkers e olgim.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 121.6 kB
Formato Adobe PDF
121.6 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
bioamrkers+e+olgim-Post_print.pdf

Open Access dal 10/02/2022

Tipologia: Bozza finale post-referaggio (post-print)
Licenza: Creative commons
Dimensione 680.8 kB
Formato Adobe PDF
680.8 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3056641
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact